Covid-19 pandemic: India's vaccination coverage crosses 157.91 cr doses

The daily vaccination tally is likely to go up when the final numbers for the day are compiled by late night

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

India's cumulative COVID-19 vaccination coverage crossed 157.91 crore doses with over 68 lakh shots being administered on Monday, the Union Health Ministry said.

The daily vaccination tally is likely to go up when the final numbers for the day are compiled by late night.

More than 50 lakh (50,56,277) precaution doses have been administered to healthcare and frontline workers, and to those aged 60 and above with comorbidities, the data showed.

With the latest update, the cumulative number of doses administered in the country reached 1,57,91,63,478, the health ministry data showed.

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2, 2021.

The next phase of COVID-19 vaccination commenced from March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

The country launched vaccination for all people aged more than 45 years from April 1, 2021.

The government then decided to expand its vaccination drive by allowing everyone above 18 to be vaccinated from May 1 last year.

The next phase of COVID-19 vaccination has commenced from January 3 this year for adolescents in the age group of 15-18 years.

India began administering precaution doses' of COVID-19 vaccine to healthcare and frontline workers including personnel deployed on poll duty and those aged 60 and above with comorbidities from January 10 amid the country witnessing a spike in infections, driven by the Omicron variant of the virus.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Mon, January 17 2022. 22:13 IST
RECOMMENDED FOR YOU